Chronic Granulomatous Disease Study in China

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02231996

Enrollment

Registered

2014-09-04

Start date

2014-09-30

Completion date

Unknown

Last updated

2014-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Granulomatous Disease, Chronic

Brief summary

CGD is a rare inherited primary immunodeficiency which is caused by the defect in one of the subunits of NADPH oxidase complex.We tend to collect and analyze Chinese CGD patients who are diagnosed in hospitals affiliated to Shanghai Jiao Tong University School of Medicine, including clinical feature, laboratory data and genetic information. we aim to find out clinical, distribution, genetic characteristic of CGD in Chinese population, etc., thus further improving the level of diagnosis and treatment for CGD.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Days to 18 Years

Healthy volunteers

Inclusion criteria

* x-linked and AR-linked Chronic Granulomatous Disease * history of life-threatening severe infections * A functional assay demonstrating abnormal NADPH oxidase function or clinical history consistent with CGD

Exclusion criteria

* Presence of other primary immunodeficiency syndromes that do not meet the clinical and laboratory criteria for CGD.

Design outcomes

Primary

Measure	Time frame
times of pneumonia	2 years

Countries

China

Contacts

Primary Contactjing wu

wujingecnu@163.com

Outcome results